Patent Yard Sign in
Expired European patentEurope

Therapeutic treatment of eosinophilia using chymase inhibitors as the active ingredient

EP 1174151 B1 · Applicant: Daiichi Asubio Pharma Co., Ltd.

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed February 22, 2001 and granted January 24, 2007. A European patent lasts at most 20 years from filing, so its term ended February 22, 2021.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by August 22, 2026.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledFebruary 22, 2001
PublishedJanuary 23, 2002
GrantedJanuary 24, 2007
Term endedFebruary 22, 2021
Application numberEP 01906225
Classification (CPC)A61P43/00 +2 more

Timeline

Timeline From EPO dates

2002200420062008201020122014201620182020Application filedFeb 22, 2001PublishedJan 23, 2002Patent grantedJan 24, 2007Term endedFeb 22, 2021

Sources & verification